Skip Navigation

This Article
Right arrow Abstract Freely available
Right arrow Print PDF (112K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Li, Y
Right arrow Articles by Altman, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y
Right arrow Articles by Altman, S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1995 Oxford University Press 835-843

Footnote

Cleavage by RNase P of gene N mRNA reduces bacteriophage [lambda] burst size

Cleavage by RNase P of gene N mRNA reduces bacteriophage [lambda] burst size Ying Li* and Sidney Altman +

Department of Biology, Yale University, New Haven , CT 06520, USA

Received December 5, 1995; Accepted January 17, 1996

ABSTRACT

RNase P, an enzyme essential for tRNA biosynthesis, can be directed to cleave any RNA when the target RNA is in a complex with a short, complementary oligonucleotide called an external guide sequence (EGS). RNase P from Escherichia coli can cleave phage [lambda] N mRNA in vitro or in vivo when the mRNA is in a complex with an EGS. The EGS can either be separate from or covalently linked to M1 RNA, the catalytic RNA subunit of RNase P. The requirement for Mg 2+ in the reaction in vitro is lower when the EGS is covalently linked to M1 RNA. Substrates made of DNA can also be cleaved by RNase P in vitro in complexes with RNA EGSs. When either kind of EGS construct is used in vivo , burst size of phage [lambda] is reduced by >= 40%. Reduction in burst size depends on efficient expression of the EGS constructs. The product of phage [lambda] gene N appears to function in a stoichiometric fashion.

INTRODUCTION

RNase P, an enzyme with an RNA subunit, can be employed to regulate artificially the expression of genes in vivo ( 1 - 3 ) and in vitro ( 4 ). This regulation is achieved by creating a complex made of a target mRNA with a small oligoribonucleotide (EGS) that resembles natural substrates for RNase P. Thus, the target mRNA is cleaved by RNase P and remains untranslated. This technology can be used both to gain insight into the function of genes and as a means of regulating the expression of genes that are important in pathogenic processes. We show here for the first time that the efficiency of bacteriophage replication in a procaryote can be diminished with this method.

The lytic cycle of bacteriophage [lambda] is governed by a series of complex regulatory steps. The N gene, the product of which functions as an antiterminator of transcription, is expressed early in infection and controls the further expression of several genes essential for the complete initiation of the lytic cycle. Since the N gene is so critical, we have chosen N mRNA as a target for inactivation by RNase P from E.coli to demonstrate the potential therapeutic value of this method of gene inactivation. We now show that N mRNA in combination with two kinds of EGS constructs can be cleaved in vitro by RNase P. Furthermore, when these EGS RNAs are expressed in vivo , the burst size of phage [lambda] is reduced by 40-60%.

MATERIALS AND METHODS

Materials

IPTG, XGAL and antibiotics were purchased from Sigma Chemical Co. T4 DNA ligase, the Klenow fragment of DNA polymerase I and restriction endonucleases were purchased from New England BioLabs; T7 RNA polymerase and RNasin were purchased from Promega Biotec; Rapid Hybridization buffer and radiolabeled chemicals were from Amersham; Sequenase was from US Biochemical Corporation; T4 RNA ligase and nucleotide triphosphates from Pharmacia; nylon membranes from Boehringer-Mannheim. C5 protein was a gift of Dr V. Gopalan of this laboratory.

RNA and DNA oligonucleotides were made by automated synthesizer (Dr J. Flory, Yale University School of Medicine), deprotected when appropriate and purified on 12 or 15% polyacrylamide/7M urea sequencing gels. The concentration of the purified oligonucleotides was calculated from measurements of their absorbance at 260 nm. The theoretical T m of each complex between an mRNA and its EGS was calculated as described previously ( 14 ).

DNA oligonucleotides used in this work:

HHA: 5'-CGGATGTGCTTTCCGGTCTGATGAGTCCGTGAGGACGAAACCTG-3'

HHB: 5'-GATCCAGGTTTCGTCTCACGGACTCATCAGACCGGAAAGCAC-3'

NA: 5'-AATTCGGATTCTCCTGTCACCAGGTCAC-3'

NB: 5'-ATCCGGTGACCTGGTGACAGGAGAATCCG-3'

N-DNA: 5'-GCTAACTGACAGGAGAATCC-3'

MB-24 (T7 promoter, bottom strand): 5'-CTATAGTGAGTCGTATTAATTTCG-3'

MB-28 (T7 promoter, top strand): 5'-AATTCGAAATTAATACGACTCACTATAG-3'

AK20: 5'-GCTCTCTGTTGCACTGGTCG-3'

5S1: 5'-TACCAT CG GCGCTACGGCGTTTCACTTC-3'

YL-1: 5'-TGGTTTTGCGCTTACCCCAACCAACAGGGG-3'

RNA oligonucleotide: N-substrate: 5'-GCUAACUGACAGGAGAAUCC-3'

Bacterial and phage strains

BL21(DE3), a strain of E.coli B that harbors a gene for phage T7 RNA polymerase ( 15 ) was a gift from Dr W. Studier, Brookhaven National Laboratory. T7A49, which is temperature sensitive for RNase P function and also has the gene for T7 RNA polymerase, has been described previously ( 3 ). Bacteriophage [lambda] was acquired from the American Type Culture Collection.

Plasmids

pET3040, a plasmid containing the phage T7 promoter and terminator sequences ( 16 ), was obtained from Dr W. Studier. pGFIB, a plasmid containing a lipoprotein promoter, was from Masson and Miller ( 17 ). pLT19xW, a plasmid containing gene N of phage [lambda], was a gift from Dr T-C Lin (Yale University). pGEM3Z was obtained from Promega Biotech. pACYC184 was obtained from New England BioLabs. pJA1 and pJA2 are derivatives of pUC19 that contain the gene for M1RNA under the control of T7 promoter ( 18 ); pJA2' is a subclone of pJA2 ( 19 ); p[Delta][94-204] and p[Delta]65 are derivatives of pJA2' that contain mutated M1 genes-a deletion of M1 between nucleotides 94 and 204, and a deletion of nucleotide 65 ( 11 ). pNT7DS1EGS and pNT7APEGS, which target [beta]-galactosidase and alkaline phosphatase respectively, were constructed as described ( 3 ). Other plasmids used in this work are described elsewhere ( 5 ).

Subcloning of the stem EGSs into a transcription expression vector

pNEGS, a plasmid that contains NEGS under T7 promoter control, followed by a hammer-head and T7 terminator, was constructed by ligating pGEM3Z vector (digested by Eco RI and Hin dIII restriction enzymes), hybrids of oligonucleotides NA/NB, HHA/HHB and the T7 terminator fragment ( Bam HI- Hin dIII fragment of pET3040). Before ligation, the DNA oligos were annealed and their 3' ends phosphorylated. pNT7NEGSs were subcloned from pNEGS to delete the lac repressor binding site on the plasmids ( Pvu II digestion).

Stem NEGS was transcribed by T7 RNA polymerase using the linearized template pNEGS (or pNT7NEGS) completely digested by Bst NI.

Construction of M1EGS plasmids

pM1NEGS is a pUC plasmid that contains a M1NEGS gene (M1 gene followed by a 22 nt spacer and NEGS) under T7 promoter control, followed by a hammerhead structure and T7 terminator ( 3 ). p[Delta]65NEGS and p[Delta][94-204]NEGS contain the same cloning fragments of pM1NEGS except that the M1 gene bears a deletion at nucleotide 65 or a deletion from nucleotides 94 to 204 of M1, respectively, pM1NEGS, p[Delta]65NEGS and p[Delta][94-204]NEGS were constructed by ligating the M1 gene vector (pJA2', p[Delta]65 or p[Delta][94-204] digested by Pst I and Hin dIII, with Pst I end made blunt by T4 DNA polymerase) and an NEGS insert generated by digestion of pNEGS DNA with Eco RI and Hin dIII. The Eco RI end was made blunt with Klenow polymerase. The M1NEGS hammerhead construct was transcribed with T7 RNA polymerase on a template made by digestion of plasmid DNA with Bam HI. After self-cleavage by the hammerhead ribozyme, the M1NEGS transcript has four nucleotides downstream from the 3' CCA sequence as indicated in the legend to Figure 1 .


Figure 1 . Schematic structure of M1NEGS and its target N mRNA substrate. The sequences of the NEGS and of the N mRNA substrate are specified. The M1NEGS actually has four additional nucleotides at its 3' end, GGTC, that are generated by hammerhead cleavage of the long T7 RNA polymerase transcript (see text). The arrow indicates the expected site of cleavage by M1 RNA. The coiled region represents M1 RNA and the box represents the spacer between M1 RNA and the EGS. The stem EGS-N mRNA complex contains the two respective sequences shown with no spacer attached and, therefore, no covalent linkage to M1 RNA.

Subcloning of gene N into a transcriptional expression vector

pGEM3Z-N is a plasmid that contains phage [lambda] gene N under T7 promoter control. It was constructed by ligating pGEM3Z vector (cut by Xma I and Hin cII) and the insert (fragment between Bfa I and Bsp EI from pLT19xW). The new plasmid contains ~2700 bp and the gene for Amp resistance.

N mRNA was transcribed by T7 RNA polymerase using the linearized template pGEM3Z-N (cut by Hin dIII or Hpa I).

Cloning of gene N under control of a constitutive expression promoter

pACYC184, which contains a different origin of replication from pBR322 or pUC19 derivatives (such as pM1NEGS), was chosen as the vector for gene N. To put gene N under the constitutive expression promoter, the lipoprotein promoter, control p1ppN was constructed by ligating the gene N fragment (insert of pGEM3Z-N plasmid from Eco RI to Hin dIII) to vector pGFIB1 (cut with Pst I and Eco RI). Thus, plppN is a pBR322 plasmid that carries a gene N under the control of the lipoprotein promoter. The insert in plppN was cut out with Nar I and Hin dIII and ligated to pACYC184 vector (cut by Nru I and Hin dIII). The latter plasmid, named pAlppN, can co-exist with pUC plasmid in the same cell, and should express N mRNA constitutively.

Phage [lambda] infection

For tests of stem EGS, strains of BL21(DE3) containing pUC19, pNT7NEGS, pNT7QEGS, or pNT7APEGS were used as host. Cells were grown at 37oC in LBC (LB + 100 [mu]g/ml carbenicillin) overnight, diluted 100-fold and grown to 2 * 10 8 cells/ml, then chilled on ice. Cells were collected by centrifugation at 4000 g for 10 min at 4oC, washed once with SM buffer (100 mM NaCl, 8 mM MgSO 4 , 50 mM Tris-HCl, pH 7.5, 0.01% gelatin), and resuspended in SM buffer. These exponential starter culture cells were kept on ice and could be used for up to 4 days.

Single-step infection

Exponential starter cultures were diluted 10-fold in LBC + 0.2% maltose and grown at 37oC to a cell density of 1 * 10 8 cell/ml. (OD 600 = 0.4). Each culture was then separated into two equal portions, and a final concentration of 2 mM IPTG was added to one of the portions. An additional 15 min shaking was then carried out to allow induction of T7 RNA polymerase and EGS expression. An aliquot of 1 ml was harvested at this point, and total RNA extracted. An aliquot of 0.5 ml was then infected with phage [lambda] (MOI = 3) simultaneous with addition of MgSO 4 (final concentration 10 mM). The mixture was gently vortexed and incubated at 37oC for 15 min. Phage adsorption was stopped by dilution of the mixture 10 4 -fold in the same medium. Diluted cells (1 ml) were transferred into 25 ml flasks and shaken at 280 r.p.m. for 45 min at 37oC. The cultures were further diluted to 10 2 -fold, and a final concentration of 0.5 mg/ml lysozyme was added to 1 ml of the dilution culture. After 30 min incubation on ice, the cell lysates were centrifuged and the supernatants were diluted one more time (10 2 -fold) and titrated. Burst sizes were determined by dividing the number of the progeny phage by the cell density of the infected cultures.


Figure 2 . Stem NEGS directed cleavage of N mRNA. ( A ) Assays with M1 alone. Internally 32 P-labeled N mRNA (0.1 [mu]M) was incubated at 37oC for 30 min in PEG buffer. When indicated, 0.1 [mu]M M1 RNA and 0.4 [mu]M NEGS were used for the assay. ( B ) Assays with RNase P holoenzyme in PA buffer. When indicated, 0.01 [mu]M M1 RNA, 0.1 [mu]M C5 protein, and 0.4 [mu]M NEGS were used. `enzyme', M1 RNA for (A) and RNase P holoenzyme for (B). `+', reactions with addition of NEGS or enzyme; `-', reactions without addition of NEGS or enzyme. Lane 1, no enzyme or NEGS; lane 2, enzyme only; lane 3, NEGS only; lane 4, both enzyme and NEGS. `S ', substrate, 450 nt; `P1', 3' product, 350 nt; `P2', 5' product, 100 nt. ( C ) Cleavage of N mRNA by M1NEGS. N mRNA internally labeled with 32 P (2000 c.p.m.; 0.1 [mu]M) was incubated with 0.1 [mu]M M1NEGS at 37oC for 30 min in PA buffer that lacked Mg 2+ but that was supplemented with 0, 10, 25, 50 or 100 mM MgCl 2 . The concentration of MgCl 2 used in each reaction is indicated above each lane. Non-specific products obtained at high concentration of Mg 2+ . `S', substrate, 214 nt in length; `P1', 3' product 114 nt, `P2', 5' product, 100 nt.

Northern hybridization assays

Total RNA extracted from cells was subjected to electrophoresis on polyacrylamide gels that contained 7 M urea. Bands of RNA were stained with ethidium bromide and the gel was soaked in transfer buffer (10 mM Tris-acetate, pH 7.8, 5 mM NaOAc, 1 mM EDTA) for ~20 min. The bands of RNAs were then electrotransferred to a nylon membrane over the course of 12-15 h at 250 mA. After transfer, the RNA was cross-linked to the membrane with a Stratalinker (Stratagene). Hybridization was performed in Rapid Hybridization buffer (Amersham) according to the protocol from Amersham.

Northern analysis used for detecting the N mRNA in phage [lambda] infected cells was performed using a 1% agarose gel following the protocol of Sambrook et al . ( 20 ). Total RNA (10 [mu]g) obtained from phage-infected cells were used in each sample. DNA oligo YL-1 was used as a probe for N mRNA; AK20 was used for M1 RNA.

Assays of RNase P activity

Standard reactions catalyzed by M1EGS RNA or mutant M1EGS RNA were incubated at 37oC for 15-60 min with 10 [mu]M M1EGS and an equal amount of substrate (2000-5000 c.p.m.) in PEG buffer (50 mM Tris-HCl, pH 7.5, 100 mM MgCl 2 , 100 mM NH 4 Cl) 4% polyethylene glycol 6000-7500; or in 3 M NH 4 OAc buffer (50 mM Tris-acetate, pH 7.5, 50 mM Mg(OAc) 2 , 3 M NH 4 OAc and 0.01% NP-40). Standard reactions carried out in the presence of C5 protein were incubated at 37oC for 15-60 min in 10 [mu]l total volume, in a reaction mixture that contained PA buffer (50 mM Tris-HCl, pH 7.5, 10 mM MgCl 2 , 100 mM NH 4 Cl), 0.01 [mu]M M1EGS, 0.1 [mu]M C5 protein and 0.1 [mu]M substrate (2000-5000 c.p.m.). The reactions were stopped by the addition of an equal volume of 9 M urea dye (0.02% of XC and BPB). In experiments to determine optimum Mg 2+ concentration, reactions were stopped by precipitating the RNAs with EtOH to remove salt. The dry samples were dissolved in 9 M urea dye. The samples were then analyzed on a 12% polyacrylamide/7M urea sequencing gel.

Table 1 Summary of the kinetic parameters of M1NEGS for RNA and DNA substrates

Multiple turnover

Single turnover

E/S

K m (nM)

k cat (min -1 )

k cat / K m (min -1 /[mu]M)

k cat / K m (min -1 /[mu]M)

M1N/RNA

148

4.75

32.2

292

M1N/DNA

99.4

0.01

0.10

0.70

(M1+N)/RNA

327

0.67

2.04

60.5

Assays were performed at 37oC in PEG buffer as described in Materials and Methods. For comparison, kinetic parameters of the (M1 + NEGS) reaction are also included. E/S refers to the nature of the particular M1EGS-substrate complex in each reaction.

To determine kinetic parameters of various reactions, incubation was in PEG buffer and aliquots were taken during the linear portion of the kinetics of the cleavage reaction. Parameters were calculated from Lineweaver-Burk plots ( 21 ) for multiple turnover or as described by Fedor and Uhlenbeck ( 22 ) for single turnover.


Figure 3 . M1NEGS and (M1 + NEGS) cleavage of a DNA substrate. One nM 5' end-labeled N-DNA oligonucleotide was assayed with 0.1 [mu]M M1NEGS (or 0.1 [mu]M M1 and 0.4 [mu]M NEGS) at 37oC for 30 min in PA buffer containing 0, 100, 200, 300, 400, 500 or 600 mM MgC1 2. `S', substrate; `P', 5' product. The two cleavage products observed in reactions in which no Mg 2+ was added could be the result of non-specific hydrolysis, the migration of those products are not the same as the M1 RNA cleavage product observed in the other lanes.

In all experiments, the fraction of substrate cleaved in various experiments was determined by analysis of gels with a beta particle detector (Betagen Betascope) or a Bio-Image-Analyzer BAS2000 (Fuji).

Transcription in vitro and purification of RNA

RNAs over 30 nt long were transcribed by T7 RNA polymerase as described by Vioque et al . ( 17 ) after digestion of plasmid DNA with the appropriate restriction enzyme. RNAs smaller than 30 nt were transcribed by T7 RNA polymerase as described by Milligan and Uhlenbeck et al . ( 23 ). RNAs were purified on polyacrylamide/7M urea sequencing gels. UV shadowing, or X-ray film exposure was used to locate the RNAs on the gel. The identified RNAs were cut out of the gels, eluted and then precipitated. The dry RNA pellets were dissolved in distilled H 2 O.

RNAs that were internally labeled were prepared by using [[alpha]- 32 P]GTP in the transcription reaction and purified on acrylamide/7M urea gel. These RNAs were directly used after purification. The methods of Sambrook et al . ( 20 ) were used to label RNAs at their 5' termini.

RNAs used for enzymatic assays were heated to 65oC in PA buffer (see above) for 5 min, then slowly cooled to 22oC. This treatment was not performed with the M1NEGS used for the metal ion dependence experiments.

Preparation of total RNAs from T7A49 that contained two plasmids

RNAs from cells grown at 43oC: after growth in LBC overnight at 30oC, cells that contained two plasmids (pAlppN and pM1NEGS, or other control plasmids) were re-inoculated in the same medium at OD 600 = 0.05 and grown at 30oC to OD 600 = 0.3. The cells were then shifted to 43oC for 20 min and then split into two portions. IPTG (final concentration 2 mM) was added to one of them. Both sets of the cells (with or without IPTG) were incubated at 43oC for another 25 min. Total RNAs were extracted from the cells and used for Northern analysis. To confirm that RNase P was inactivated in cells at 43oC, samples were collected at the time points before the temperature shift, after 20 min at 43oC, and after 25 min IPTG induction, and used for preparation of the cell extracts.

RNA from cells grown at 30oC: cells were treated as above except for the following difference. Instead of shifting the temperature, cells were kept at 30oC: the time for IPTG induction at 30oC was twice as long as that at 43oC.

RESULTS

Cleavage of N mRNA in vitro

A target site in N mRNA for cleavage by RNase P was chosen according to its susceptibility to RNase T 1 in vitro ( 4 , 5 ). Two different EGSs were used to direct RNase P to this site which is located 50-60 nt downstream from the AUG at the 5' end of the message: one, a simple oligonucleotide called a stem EGS ( 4 ; Fig. 1 ) and the second, an EGS covalently linked to the 3' end of M1 RNA (M1NEGS), the catalytic RNA subunit of RNase P ( 2 ; Fig. 1 ), which was developed from studies of substrates linked to M1 RNA ( 5 - 9 ). Complexes of N mRNA with both such EGSs can be cleaved readily in vitro as shown in Figure 2 . Panels A and B show that the target mRNA in a complex with stem NEGS can be cleaved by both M1 RNA alone and the holoenzyme complex (M1 RNA plus C5 protein), the latter at much lower concentrations of enzyme and lower ionic strength than the former. Panel C shows cleavage by M1NEGS: unlike the reaction shown in panel B, on addition of C5 protein to the reaction with M1NEGS, no significant increase in cleavage rate is seen (data not shown). All these reactions can be driven to completion by the addition of more enzyme.

The reaction of M1 RNA, the catalytic RNA subunit of E.coli RNase P, and the holoenzyme complex (M1 RNA with C5 protein) with stem EGSs has been described previously ( 4 , 10 ) but the properties of M1EGS, particularly of that with M1NEGS, have not been fully characterized. We showed, as have others for different covalent M1-substrate constructs ( 2 , 7 , 8 , 9 ) that the latter reaction is intramolecular in buffers that contain low concentration of Mg 2+ but acquires significant intermolecular properties at high Mg 2+ ( 5 ). The reaction of M1NEGS reaches an optimum at ~50 mM Mg 2+ (see Fig. 2 C), whereas that with a separate EGS reaches an optimum at ~200 mM Mg 2+ (data not shown). We also confirmed that there is an optimum length of the spacer linking the EGS to M1 in M1EGS constructs (~25 nt in this case), and that the pH dependence of the reaction slopes gently upward between pH 6 and 9 in single-turnover reactions, and that Ca 2+ and Mn 2+ can substitute for Mg 2+ in the reaction buffer although at lower rates at equivalent concentrations of divalent cations ( 5 ).


Figure 4 . ( A ) Expression of the stem NEGS as detected by Northern analysis. Total RNAs (10 [mu]g) extracted from cells containing pNT7NEGS plasmid were electrophoresed on an 8% polyacrylamide/7M urea gel and transferred to a nylon membrane. Hybridization was performed using a 32 P end-labeled DNA oligonucleotide NB (complementary to the NEGS). Samples obtained from cells containing pNT7NEGS (lanes 1 and 2), no IPTG induction (lane 1), IPTG induction (lane 2), markers lane (lane 3). ( B ) Expression of M1NEGS as detected by Northern analysis. Total RNA (10 [mu]g) extracted from each sample was electrophoresed on 6% polyacrylamide/7 M urea gel and transferred to a nylon membrane. Hybridization was performed using a 32 P- labeled DNA oligonucleotide NB (complementary to the NEGS) as a probe. Samples obtained from cells that contained pM1NEGS (lanes 1 and 3), cells containing p[Delta]65NEGS (lanes 2 and 4). No IPTG induction (lanes 1 and 2), IPTG induction (lanes 3 and 4). Marker lane (lane 5).


Figure 5 . Reduction of the N mRNA by over-expression of stem NEGS. Cells transformed with three different plasmids were infected with phage [lambda] at log phase. To induce over-expression of stem EGS, 2 mM IPTG was added 15 min before the infection. Total RNA (10 [mu]g) extracted from each sample taken at the time of 0, 5, 10, 20 or 30 min after infection were used for Northern analysis. DNA oligo YL-l was used as a probe for N mRNA, DNA oligo AK20 was used as a probe for M1 RNA. The amount of N mRNA (in c.p.m.) was normalized by the amount of M1 RNA in the same sample. Figures depict the time course of the N mRNA in the three cells,with ([utrif] ) or without ( [squ]) IPTG induction. ( A ) Cells containing plasmid pNT7APEGS. ( B ) Cells containing plasmid pNT7DS1EGS. ( C ) Cells containing plasmid pNT7NEGS. ( D ) Comparison of the amount of the N mRNA at 10 min after infection. `Relative N mRNA', the amount of N mRNA in cells with IPTG induction divided by the one in cells without IPTG induction. Taking the amount of N mRNA in cells without IPTG induction as 100, the average of the amount of N mRNA is 93 for `Control' (the average from cells containing pNT7APEGS and containing pNT7DS1EGS) and 63 for `NEGS' (cells containing pNT7NEGS).

C5 protein does not stimulate the intramolecular reaction significantly in PA buffer (see Materials and Methods), nor does the protein bind in the same way to M1NEGS RNA as it does to M1 RNA alone as determined by gel shift assays ( 5 ). C5 protein does enhance the intermolecular reaction carried out by M1NEGS just as it does for the analogous reaction with stem NEGS and M1 RNA (Fig. 2 B). Deletion mutants of M1 RNA that lack significant catalytic activity ([Delta]65 and [Delta][94-204]; 11 ) act as negative controls since the rate of the intramolecular reaction is much reduced in these M1NEGS constructs ( 5 ).

The reaction of both M1 + NEGS and M1NEGS with a DNA substrate produces the expected cleavage products (Fig. 3 ). The M1NEGS construct cleaves DNA in buffers that contain 200 mM Mg 2+ much more efficiently than does M1 + NEGS. The kinetic parameters of the reaction with both RNA and DNA substrates are shown in Table 1 . The M1NEGS construct binds both RNA and DNA substrates more tightly than does M1 RNA alone. The lack of 2' OH groups in a substrate primarily affects the k cat of the reaction under multiple turnover conditions and results in a reduction of that parameter of ~500-fold. For both multiple and single turnover, k cat / K m for a DNA target is ~300-fold lower than for M1NEGS with an RNA target.

Expression of NEGS and M1NEGS in vivo and their effect on phage [lambda] burst size

Plasmids that contained the genes for NEGS and a variety of M1NEGS, as well as controls, were constructed and inserted into E.coli (see Materials and Methods). The genes of interest were under the control of a phage T7 promoter and were followed by a hammerhead ribozyme that insured appropriate post-transcriptional processing of the gene transcript. The host strain harbors a gene for T7 RNA polymerase that is inducible by IPTG. The expression of NEGS and M1NEGS after induction by IPTG but prior to infection was checked by Northern blot analysis and quantitation of NEGS and M1NEGS was normalized to a control 5S rRNA control (Fig. 4 ). The Northern blot analysis indicated that not all of the stem EGS gene transcripts were efficiently processed by the hammerhead ribozyme (Fig. 4 A, lane 2). A faint band representing NEGS of expected length is visible in lane 2. In this respect, the hammerhead ribozyme in the M1NEGS transcript functioned better than the NEGS transcript (Fig. 4 B, lanes 3 and 4) since the full-length M1NEGS is readily observable and few higher molecular weight products, perhaps due to inefficient termination of transcription, are seen. As can be seen in Table 2 and Figure 4 , the level of M1NEGS was increased ~8-fold on addition of IPTG to the cultures, and the increase for stem NEGS long transcript is clear in Figure 4 A: its net increase is probably at least four-fold. As the plasmids that harbored genes for EGSs were behaving as anticipated, the appropriate cell lines were then infected with phage [lambda] in the absence or presence of IPTG (see Materials and Methods).

Both NEGS and M1NEGS, when overexpressed, were capable of reducing phage [lambda] burst size as determined by comparison of the relative burst sizes measured in cells harboring plasmids coding for NEGS or M1NEGS with cells harboring control plasmids (Table 3 ). In both cases, the average of several experiments yielded a reduction of >= 40% in burst size. An EGS directed to the late phage [lambda] gene Q mRNA showed a modest inhibiting capability (10%), as did [Delta]65 M1NEGS (14%).

In cells harboring pNEGS, the amount of N mRNA in infected cells was quantitated by hybridization analysis and the results are shown in Figure 5 . Cells harboring control plasmids showed no difference in the kinetics of appearance and decay of N mRNA whereas cells that contained a plasmid coding for NEGS showed a relative decrease of ~40% in N mRNA after induction of the NEGS gene (Fig. 5 C), similar to the reduction of burst size. The estimated amounts of NEGS and M1NEGS RNAs (400-550 copies/cell) and N mRNA (200-300 copies/cell) in infected cells are roughly similar 5 min after infection. It is possible, therefore, that the product of the N gene acts in a stoichiometric fashion since the absolute decrease in its mRNA parallels the absolute decrease in burst size.

Table 2 Estimated amount of EGS RNA expressed in cells prior to infection

No IPTG

IPTG

Induction of EGS

Number of EGS /Cell

Number of EGS /Cell

(IPTG/No IPTG)

pM1NEGS

60

475

7.9

p[Delta]65NEGS

68

556

8.2

p[Delta][94-204]NEGS

99

505

5.1

pNT7NEGS

N/A

377

N/A

The amount of EGS RNA was estimated by Northern analyses (see Materials and Methods). BL21(DE3) that contained pNT7NEGS, pM1NEGS, p[Delta]65NEGS, or p[Delta][94-204]NEGS was subjected to induction by IPTG. Samples were collected from these cells as well as from cells that were not induced. Total RNA was extracted for Northern analyses. Both EGS and 5S RNA were probed using the same filter, and the amount of EGS was estimated using 18 700 copies/cell of 5S RNA as a standard (24). The efficiency of induction of EGS RNA in the presence of IPTG was calculated by dividing the amount of EGS RNA in these cells by the amount in cells that were not induced. No signal for NEGS was detected in cells containing pNT7NEGS to which no IPTG had been added. `N/A', not available.

Table 3 (A) Summary of phage [lambda] burst sizes of cells that contained plasmids coding for stem EGS a. (B) Smmary of phage [lambda] burst sizes of cells that contained plasmids coding for M1NEGS b
A. M1NEGS

Average (four experiments) of the relative burst: IPTG/No IPTG

pUC19

0.9 +- 0.1

pM1HH

0.9 +- 0.1

p[Delta][94-204]NEGS

1.0 +- 0.2

pM1NEGS

0.6 +- 0.02

p[Delta]65NEGS

0.8 +- 0.1

Reduction of the burst: average of relative burst of pUC19, pM1HH, and p[Delta][94-204]NEGS as control

control M1EGSs

0%

pM1NEGS

33%

p[Delta]65NEGS

14%

B. NEGS

Average (three experiments) of the relative burst: IPTG/No IPTG

pUC19

0.9 +- 0.1

pNT7APEGS

1.1 +- 0.1

pNT7QEGS

0.9 +- 0.4

pNT7NEGS

0.4 +- 0.02

Reduction of the burst: average of relative burst of pNT7APEG and pUC19 as control

Control EGSs

0%

pNT7QEGS

10%

pNT7NEGS

60%

a BL21(DE3) that contained pUC19, pNT7APEGS, pNT7QEGS or pNT7NEGS was used. Relative burst size was calculated by dividing the burst size of IPTG-induced cells by the burst size of uninduced cells. Average of the relative burst was calculated by taking the average of the results of three sets of experiments. Reduction of the burst size was calculated using the average relative burst of cells containing pUC19 and cells containing pNT7APEGS as 1.0. For the control plasmids, the number of plaque forming units released was generally 100-200 /cell in both induced and uninduced cells. b BL21(DE3) that contained plasmid pUC19, pM1HH, p[Delta][94-204]NEGS, p[Delta]65NEGS or pM1NEGS was used. Relative burst was calculated by dividing the burst size of IPTG-induced cells by the burst size of uninduced cells. Average of the relative burst was calculated by taking the average of the results of the four sets of experiments. Reduction of the burst was calculated using the average relative burst of cells containing pUC19, pM1HH and p[Delta][94-204]NEGS as 1.0. For control plasmids, the number of plaque forming units released was generally 100-200/cell in both induced and uninduced cells.

Table 4 Reduction of the amount of N mRNA in T7A49 cells containing two plasmids

Relative amount of N mRNA (IPTG/No IPTG)

43oC

30oC

Set 1

Set 2

Set 3

Average

Reduction (%)

Set 4

Set 5

Average

Reduction (%)

pM1NEGS

0.46

0.48

0.54

0.47 +- 0.09

53

0.38

0.39

0.34 +- 0.05

66

pM1NEGS

0.58

0.31

0.29

p[Delta]65NEGS

0.53

0.9

0.88

0.72 +- 0.19

28

0.78

0.48

0.63 +- 0.15

37

pM1QEGS

1.96

0.77

1.23

1.37 +- 0.60

0

1.08

0.95

1.02 +- 0.07

0

p[Delta][94-204]NEGS

1.29

1.57

0.77

1.21 +- 0.33

0

1.43

1.32

1.38 +- 0.06

0

Analyses of three Northern blots performed at 43oC and two at 30oC are summarized. .

The amount of N mRNA was calculated using 5S RNA as an internal control. The relative amount of N mRNA was calculated by dividing the amount of N mRNA from cells involved with IPTG by the amount from cells with no IPTG induction

An independent measure of the ability of M1NEGS RNAs to target N mRNA was carried out in cells that contained a plasmid coding for over-expression of N mRNA and another compatible plasmid coding for M1NEGS. In these cells (T7A49; see Materials and Methods), which were also temperature sensitive for function of C5 protein, reduction of N mRNA levels from an initial value of 600-800 copies/cell was 37% for [Delta]65NEGS and 66% for M1NEGS (Table 4 ). At the restrictive temperatures, the inhibition was somewhat less effective. Levels of 5S RNA were used as an internal standard in these experiments.

DISCUSSION

RNA enzymes can be used to inhibit gene expression in mammalian cells in tissue culture ( 2 , 12 ) as well as in E.coli ( 3 , 13 ). The inhibition of procaryote genes attained in E.coli is less than the corresponding levels attained in eucaryotes, possibly because of the tighter coupling of transcription and translation in E.coli . We have found that RNase P, in combination with EGSs targeted to N mRNA can be used to reduce the burst size of bacteriophage [lambda] by 40-60%. This result is statistically significant and can be correlated with corresponding reductions in the levels of N mRNA in vivo as measured by Northern blots. The latter results, however, measure intact N mRNA as well as fragments that still hybridize to our probe. The methodology we used must be developed further (e.g. through the use of multiple EGS genes targeting different sites in [lambda] mRNAs) to be an effective agent in controlling virus infection of bacteria, but it may have further utility now for the study of gene function, especially for genes the products of which act in a stoichiometric fashion. Our data suggest that the N gene product acts in this way. As indicated above, a stem EGS targeted to the Q gene of phage [lambda], a late gene that controls transcription of other genes, inhibited burst size by only 10%. It is possible that our choice of target sites in both the N and Q genes, while advantageous in vitro , were not optimal in guiding RNase P in vivo . More effective sites could be identified by chemical footprinting in vivo of target mRNAs rather than by nuclease susceptibility in vitro .

We have also characterized in vitro , in part, the properties of the reaction of covalently linked M1 RNA and an EGS RNA (M1NEGS) with its target, [lambda] N mRNA. This catalytic construct binds and cleaves substrate, DNA or RNA, more efficiently than does M1 RNA alone in combination with a separate EGS. A construct containing a large deletion [Delta][94-204] NEGS, in M1 RNA responds only poorly to the presence of C5 protein in vitro ( 11 ) and served as a control in vivo : it has much less activity in vivo than wild type M1NEGS, thereby showing that the inhibitory effect of M1NEGS alone is not due solely to an anti-sense effect as has also been demonstrated by Liu and Altman ( 2 ) and Guerrier-Takada et al . ( 3 ).

ACKNOWLEDGEMENTS

We thank our colleagues, especially Dr C. Guerrier-Takada, for advice, encouragement and exchange of data. This research was supported by grant GM19422 from the National Institutes of Health of the USA.

REFERENCES

1 Yuan,Y., Hwang,E-S. and Altman,S. (1992) Proc. Natl. Acad. Sci. USA 89, 8006-8010. MEDLINE Abstract

2 Liu,F. and Altman,S. (1995) Genes Dev. 9, 471-480. MEDLINE Abstract

3 Guerrier-Takada,C., Li,Y. and Altman,S. (1995) Proc. Natl. Acad. Sci. USA 92, 11115-11119.

4 Li,Y., Guerrier-Takada,C., and Altman,S. (1992) Proc. Natl. Acad. Sci. USA 89, 3185-3189. MEDLINE Abstract

5 Li,Y. (1995) Ph.D. Dissertation, Yale University, New Haven, CT, USA.

6 Altman,S. (1989) Adv. Enzymol. 62, 1-36.

7 Kikuchi,Y., Sasaki-Tozawa,N., and Suzuki,K. (1993) Nucleic Acids. Res. 21, 4685-4689. MEDLINE Abstract

8 Kikuchi,Y. and Suzuki-Fujita,K. (1994) J. Biochem. 117, 197-200.

9 Frank,D.N., Harris,M.E. and Pace,N.R. (1994) Biochemistry 33, 10800-10808. MEDLINE Abstract

10 Forster,A.C. and Altman,S. (1989) Science 249, 783-786. MEDLINE Abstract

11 Guerrier-Takada,C. and Altman,S. (1992) Proc. Natl. Acad. Sci. USA 89, 1266-1270.

12 Yamada,O., Kraus,G, Leavitt,M.C., Yu,M. and Wong-Staal,F. (1994) Virology 205, 121-126. MEDLINE Abstract

13 Sioud,M. and Drlica,K. (1991) Proc. Natl. Acad. Sci. USA 88, 7303-7307. MEDLINE Abstract

14 Freier,S.M., Kierzak R., Jaeger,J.A., Sugimoto,N., Caruthers,M.H., Neilson,T.and Turner,D.H. (1986) Proc Natl. Acad. Sci. USA 83, 9373-9377. MEDLINE Abstract

15 Studier,F.W. and Moffatt,B.A. (1986) J. Mol. Biol. 189, 113-130. MEDLINE Abstract

16 Rosenberg,A.H., Lade,B.N., Chui,D., Lin,S-W, Dunn,J.J. and Studier,F.W. (1987) Gene 56, 125-135. MEDLINE Abstract

17 Masson,J.M. and Miller,J.H. (1986) Gene 47, 179-183. MEDLINE Abstract

18 Vioque,A., Arnez,J. and Altman,S. (1988) J. Mol. Biol. 202, 835-848. MEDLINE Abstract

19 Guerrier-Takada,C., Lumelsky,N., and Altman,S. (1989) Science 246, 1578-1584.

20 Sambrook,J., Fritsch,E.F., and Maniatis,T. (1989) Molecular Cloning: A Laboratory Manual, second edition. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.

21 Fersht,A. (1985) W.H. Freeman and Company, NY.

22 Fedor,M.J. and Uhlenbeck,O.C. (1992) Biochemistry 31, 12042-12054. MEDLINE Abstract

23 Milligan,J.F. and Uhlenbeck,O.C. (1988) Methods Enzymol. 180, 51-62.

24 Lederberg, J. (1992) Encyclopedia of Microbiology, Academic Press, San Diego, CA.


Return

* To whom correspondence should be addressed

+ Present address: Boehringer-Ingelheim Corporation, Danbury, CT 06877, USA
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Bacteriol.Home page
M. R. Chenoweth and S. Wickner
Complex Regulation of the DnaJ Homolog CbpA by the Global Regulators {sigma}S and Lrp, by the Specific Inhibitor CbpM, and by the Proteolytic Degradation of CbpM
J. Bacteriol., August 1, 2008; 190(15): 5153 - 5161.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
D. Plehn-Dujowich and S. Altman
Effective inhibition of influenza virus production in cultured cells by external guide sequences and ribonuclease P
PNAS, June 23, 1998; 95(13): 7327 - 7332.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
H. A. James and I. Gibson
The Therapeutic Potential of Ribozymes
Blood, January 15, 1998; 91(2): 371 - 382.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
C. Guerrier-Takada, R. Salavati, and S. Altman
Phenotypic conversion of drug-resistant bacteria to drug sensitivity
PNAS, August 5, 1997; 94(16): 8468 - 8472.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Print PDF (112K) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (12)
Right arrowRequest Permissions
Right arrow Commercial Re-use Guidelines
for Open Access NAR Content
Google Scholar
Right arrow Articles by Li, Y
Right arrow Articles by Altman, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Li, Y
Right arrow Articles by Altman, S
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?